According to Narita et al. [15], hyperthermia and HDAC inhibitors can be a possible modality for cancer therapy because specific inhibitors of HDAC could enhance the antitumour effects of hyperthermia without any severe side effects. The gene discussed is HDAC9; the disease is cancer.